Quality of Life as an outcome in cancer clinical trials is an often overlooked but key aspect of the outcome of new cancer treatments.

Most Americans use social media, making it a crucial tool in oncology, where new findings, biomarkers, treatments, and trials are presented.

Education about cancer clinical trials can increase trial enrollment by improving impressions, reducing fears, and raising awareness.

Patient Navigators increase the awareness and knowledge of people with cancer about clinical trials, leading to improved enrollment rates.

Provisions in the IRA intend to lower drug costs, yet unintended consequences to this goal will likely cost far more than the money saved.

After the COVID-19 pandemic, cancer clinical trials adopted a more patient-centric approach where trials work better for participants.

Liquid biopsy for cancer is non-invasive and easily repeated, permitting molecular profiling and many other purposes with strong accuracy.

Patient advocacy groups provide support, education, advocacy, and information sharing while including the patient perspective in healthcare.

Making decisions about medical treatment can be challenging and stressful. Furthermore, challenge and stress are magnified when deciding...

The development of life-saving treatments depends on clinical trials, which rely on ethical guidelines to ensure participants' safety.

The patient voice is vital to understanding how to guide and build the best possible tools to treat people with cancer effectively.